< Back to the Blog

About the author

Amy Divaraniya
Dr. Aparna (Amy) Divaraniya is the Founder and CEO of Oova. She has over 10 years experience working in data science and a PhD in Biomedical Sciences. In 2017, Amy pivoted to women's healthcare after facing her own fertility struggles. Amy started Oova to give women control over their fertility by making high-quality hormone testing more accessible.

Sources

  1. ASRM fertility evaluation committee opinion. LH testing, timed progesterone, and clinical assessment.
  2. ASRM patient fact sheet on ovulation detection. Timing and interpretation of temperature and other methods.
  3. ACOG fertility awareness methods and IPPF medical and service delivery guidelines. Temperature collection and factors affecting interpretation.
  4. ASRM fertility evaluation committee opinion 2021. BBT limitations and unclear biphasic patterns in ovulatory cycles.
  5. Oura temperature measurement guidance. Skin temperature versus conventional BBT.
  6. Distinct urinary progesterone metabolite profiles during the luteal phase. Primary research on urinary progesterone metabolite patterns.
  7. ASRM luteal phase deficiency committee opinion. Diagnostic limitations.
  8. Oova guidance on FSA and HSA purchases. Plan-dependent eligibility and documentation.

About the Oova Blog:
‍Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.